INIS
synthesis
100%
cancer
90%
receptors
82%
humans
74%
evaluation
72%
indoles
61%
inhibition
61%
tryptophan
53%
design
50%
carbonic anhydrase
45%
in vitro
42%
tumors
39%
immunotherapy
38%
nanoparticles
35%
enzymes
31%
urea
31%
in vivo
31%
aggregation
30%
drugs
25%
arachidonic acid
25%
muscles
24%
prostaglandins
22%
molecules
20%
proteins
19%
titanium carbides
19%
dispersions
19%
silicon carbides
19%
rats
19%
pigs
18%
comparative evaluations
17%
range
17%
doses
16%
modeling
16%
screening
15%
chymotrypsin
15%
thrombin
15%
values
14%
diuretics
14%
hydrogen 1
14%
therapy
13%
thiazoles
13%
oxidases
13%
crystals
13%
investigations
13%
toxicity
13%
anticonvulsants
13%
isomers
13%
structure-activity relationships
12%
plasma
11%
arteries
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
57%
Tryptophan 2,3 Dioxygenase
46%
Indoleamine 2,3 Dioxygenase
44%
Immunotherapy
36%
Thromboxane Synthase Inhibitor
35%
Thromboxane A2 Receptor Blocking Agent
30%
Neoplasm
29%
Indole Derivative
27%
Indole
27%
Thromboxane Receptor
26%
Thromboxane
21%
Indoleamine 2,3 Dioxygenase Inhibitor
20%
Tryptophan
19%
Harmine
18%
Thromboxane A2
17%
Virtual Screening
17%
IC50
16%
Thromboxane Synthase
15%
Carbonate Dehydratase IX
14%
Arachidonic Acid
14%
Structure Activity Relationship
14%
Torasemide
13%
Thromboxane Receptor Blocking Agent
13%
Coumarin Derivative
13%
Immunomodulating Agent
13%
Thiazole
13%
Terbogrel
13%
Carbonate Dehydratase
11%
Kynurenine
11%
Thromboxane A2 Receptor
10%
Thrombin Inhibitor
9%
Sulfonamide
9%
Isoenzyme
9%
Seratrodast
8%
Thrombin
8%
Prostaglandin
7%
Vaccination Policy
7%
Blood Clotting Factor 10a
7%
Carbonate Dehydratase Inhibitor
7%
Receptor Antagonist
7%
Nanoparticle
6%
Phenyl Group
6%
Beta Carboline Derivative
6%
Amine Oxidase (Flavin Containing) Isoenzyme A
6%
Amine Oxidase (Flavin Containing)
6%
Amine Oxidase (Flavin Containing) Isoenzyme B
6%
Poloxamer
6%
Contraceptive Agent
6%
Cyclodextrin
6%
Prostacyclin
6%
Keyphrases
Promising Target
14%
1H-indole
14%
Indoleamine 2,3-dioxygenase 1 (IDO1)
14%
Tryptophan 2,3-dioxygenase (TDO2)
13%
Anticancer Immunotherapy
13%
Crystalline Properties
13%
Pyridinyl
13%
Novel Inhibitors
13%
Ethanones
13%
Cancer Cells
12%
Cancer Therapy
11%
Indoleamine 2,3-dioxygenase Inhibitor
8%
3-dioxygenase Inhibitor
7%
Immune Rejection
7%
Biological Evaluation
7%
Tryptophan Depletion
6%
Natural Immune System
6%
Enzymatic Mechanism
6%
Efficacy in Vivo
6%
Proteomic Investigation
6%
β-Carboline Derivatives
6%
Myocardial Ischemia-reperfusion
6%
Electronic Properties
6%
Tsitsikammamine
6%
Orally Active
6%
Immune Resistance
6%
Marine Alkaloids
6%
Prostacyclin
6%
Thromboxane Receptor
6%
Urea
6%
Receptor Antagonism
6%
Thromboxane Synthase
6%
Tert-butyl
6%
Dual-acting
6%
Thromboxane
6%
Regulatory Needs
6%
Unmet Medical Need
6%
Contraceptives
6%
Structure-based Design
6%
Clinical Investigation
6%
Resistance Test
6%
Dispersant
6%
Gene-deficient Mice
6%
Coated Glass
6%
Surface Cell
6%
Glass Coverslips
6%
Carbonic Anhydrase VII
6%
Chymotrypsin
6%
Coumarin
6%
Inhibition Mechanism
6%
